Raptor Pharmaceuticals Corp. (RPTP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: November 19, 2014
Pages: 43
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: R24D3E52FE0EN
Leaflet:

Download PDF Leaflet

Raptor Pharmaceuticals Corp. (RPTP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Raptor Pharmaceuticals Corp. (Raptor) is a biopharmaceutical company. It develops and commercializes drugs that help in treating debilitating and fatal diseases. The company’s product, Procysbi, for the treatment of a rare genetic disorder, nephropathic cystinosis, received marketing approval from the US FDA and European Commission in 2013. Its clinical stage product candidates include RP103, for the treatment of Huntington’s disease (Phase II/III), non-alcoholic fatty liver disease (NAFLD) in children (Phase II) and Leigh syndrome and other mitochondrial diseases (Phase IIb); Convivia (oral 4-methylpyrazole), for the treatment of acetaldehyde toxicity due to ALDH2 deficiency. The company’s preclinical programs include HepTide, for the treatment of primary liver cancer; and ADO (cysteamine dioxygenase), for the treatment of diseases for which cysteamine is a medicine. Some of the company’s major partners include DaVita Clinical Research, National Institute of Diabetes & Digestive & Kidney Diseases, Uni Pharma Co., Ltd, Johns Hopkins University, McGill University, The Cystinosis Foundation, The Huntington's Disease Society of America and others. Raptor is headquartered in Novato, California, the US.

Raptor Pharmaceuticals Corp. (RPTP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Medical Devices Deals, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deal Details
Partnerships
Raptor Pharma Enters Into Co-Development Agreement With NIDDK For RP104
Merger
Raptor Pharma Merges With TorreyPines Therapeutics
Licensing Agreements
Raptor Pharma Enters Into Licensing Agreement With Satt Paca Corse For Rett Syndrome
Raptor Pharma Enters Into Licensing Agreement With Seattle Children's Research Institute
Raptor Pharma Enters Into Licensing Agreement With Universite Laval For IP Rights Related To Parkinson's Disease
Raptor Pharma Enters Into Licensing Agreement With McGill University For IP Rights Related To Malaria
Raptor Pharma Enters Into Licensing Agreement With University Of Iowa
Raptor Pharma Enters Into Licensing Agreement With Uni Pharma
Raptor Pharma Enters Into Licensing Agreement With Weizmann Institute And Niigata University
Raptor Pharma Enters Into An Agreement With Roche
Raptor Pharma Enters Into Licensing Agreement With University of California
Equity Offering
Raptor Pharma Announces Public Offering Of Common Stock For US$40 Million
Raptor Pharma Completes Public Offering Of Common Stock For US$46 Million
Raptor Pharma Completes Private Placement For US$15 Million
Raptor Pharma Completes Private Placement Of US$7.5 Million
Raptor Pharma Completes Private Placement Of US$2.62 Million
Raptor Pharma Completes Private Placement Of Units For US$2.4 Million
Raptor Pharma Completes Private Placement Of US$10 Million
Debt Offering
Raptor Pharma to Raise USD60 Million in Private Placement of 8% Senior Notes Due 2019
Raptor Pharmaceuticals Corp. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Key Facts, 2013
Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Deals By Therapy Area, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Medical Devices Deals, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Raptor Pharma Enters Into Co-Development Agreement With NIDDK For RP104
Raptor Pharma Merges With TorreyPines Therapeutics
Raptor Pharma Enters Into Licensing Agreement With Satt Paca Corse For Rett Syndrome
Raptor Pharma Enters Into Licensing Agreement With Seattle Children's Research Institute
Raptor Pharma Enters Into Licensing Agreement With Universite Laval For IP Rights Related To Parkinson's Disease
Raptor Pharma Enters Into Licensing Agreement With McGill University For IP Rights Related To Malaria
Raptor Pharma Enters Into Licensing Agreement With University Of Iowa
Raptor Pharma Enters Into Licensing Agreement With Uni Pharma
Raptor Pharma Enters Into Licensing Agreement With Weizmann Institute And Niigata University
Raptor Pharma Enters Into An Agreement With Roche
Raptor Pharma Enters Into Licensing Agreement With University of California
Raptor Pharma Announces Public Offering Of Common Stock For US$40 Million
Raptor Pharma Completes Public Offering Of Common Stock For US$46 Million
Raptor Pharma Completes Private Placement For US$15 Million
Raptor Pharma Completes Private Placement Of US$7.5 Million
Raptor Pharma Completes Private Placement Of US$2.62 Million
Raptor Pharma Completes Private Placement Of Units For US$2.4 Million
Raptor Pharma Completes Private Placement Of US$10 Million
Raptor Pharma to Raise USD60 Million in Private Placement of 8% Senior Notes Due 2019
Raptor Pharmaceuticals Corp., Key Competitors
Raptor Pharmaceuticals Corp., Key Employees
Raptor Pharmaceuticals Corp., Subsidiaries

LIST OF FIGURES

Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Raptor Pharmaceuticals Corp., Medical Devices Deals, 2008 to YTD 2014
Skip to top


Ask Your Question

Raptor Pharmaceuticals Corp. (RPTP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: